Toronto, Canada

Gerald J Purd'homme

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald J Purd'homme. Retrieved from https://idiyas.com/inventor/gerald-j-purd-homme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerald J Purd'homme: Innovator in Diabetes Treatment

Introduction

Gerald J Purd'homme is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of diabetes treatment through his innovative research and development.

Latest Patents

Purd'homme holds a patent for "GLP/1/exendin 4 IgG Fc fusion constructs for treatment of diabetes." This invention presents a method and composition aimed at the prevention and treatment of both type I and type II diabetes in subjects. The composition features an IgG-Fc fusion protein that includes GLP-1, mutant GLP-1, or exendin-4. He has 1 patent to his name.

Career Highlights

Throughout his career, Purd'homme has focused on advancing medical treatments, particularly in the area of diabetes. His work has the potential to improve the lives of many individuals suffering from this chronic condition.

Collaborations

Purd'homme has collaborated with various professionals in his field, including his coworker, Qinghua Wang. Their joint efforts have contributed to the development of innovative solutions in diabetes care.

Conclusion

Gerald J Purd'homme is a dedicated inventor whose work in diabetes treatment showcases his commitment to improving healthcare outcomes. His innovative approaches continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…